Figure 5.

Cumulative survival rates between corresponding groups. (A) There was no significant difference between the IFN-treated hepatitis C group (Group A) and the general resident group (Group A). (B) There was a significant difference between the hepatitis C group not receiving IFN treatment (Group B) and the general resident group (Group B) (p < 0.0001). (C) There was no significant difference between the hepatitis C group that achieved SVR by IFN treatment (Group A1) and the general resident group (Group A1). (D) There was no significant difference between the IFN treatment group with non-SVR in the hepatitis C group (Group A2) and the general resident group (Group A2) (p = 0.153). All survival rates were calculated using the Kaplan–Meier method. Solid and dotted lines represent the hepatitis C and general resident groups, respectively.

Yamasaki et al. BMC Gastroenterology 2012 12:139   doi:10.1186/1471-230X-12-139
Download authors' original image